Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M174,728Revenue (TTM) $M39,807Net Margin (%)9.9Altman Z-Score3.3
Enterprise Value $M185,449EPS (TTM) $1.4Operating Margin %15.2Piotroski F-Score6
P/E(ttm)45.5Beneish M-Score-2.7Pre-tax Margin (%)11.7Higher ROA y-yN
Price/Book4.410-y EBITDA Growth Rate %3.4Quick Ratio1.5Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %-3.4Current Ratio1.8Lower Leverage y-yN
Price/Free Cash Flow20.3y-y EBITDA Growth Rate %-11.6ROA % (ttm)4.0Higher Current Ratio y-yY
Dividend Yield %2.9PEG--ROE % (ttm)9.1Less Shares Outstanding y-yY
Payout Ratio %131Shares Outstanding M2,746ROIC % (ttm)8.5Gross Margin Increase y-yY

Gurus Latest Trades with MRK

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

MRK is held by these investors:

MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Karachun Rita ASr. VP Fince-Global Controller 2017-02-14Sell2,954$64.73-2.15view
RUSSO PATRICIA FDirector 2017-02-08Sell5,000$64.42-1.68view
WEEKS WENDELL PDirector 2017-02-06Sell5,000$64.51-1.81view
WENDELL PETER CDirector 2017-02-03Sell15,000$63.69-0.55view
Holston Michael JEVP, General Counsel 2017-02-03Sell91,959$63.96-0.97view
Schechter Adam HEVP & Pres-Global Human Health 2017-02-03Sell36,335$63.73-0.61view
Cech Thomas RDirector 2017-02-03Sell5,000$63.42-0.13view
FRAZIER KENNETH CChairman, President & CEO 2016-11-10Sell140,000$65.03-2.6view
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy 2016-11-07Sell85,523$60.025.53view
LAZARUS ROCHELLE BDirector 2016-11-02Sell20,000$59.067.25view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

News about MRK:

Articles On GuruFocus.com
Valeant: It's Not a Game of Chess Part I Mar 16 2017 
US Indexes Lower on Energy Stock Losses Mar 08 2017 
US Market Indexes Higher for the Week Mar 05 2017 
Why 3D Printing and Biotech Will Be Good Bets in 2017 Feb 23 2017 
Dow Jones Closes at 20,504.41 Feb 15 2017 
Nasdaq Reaches a New High on Wednesday Feb 08 2017 
Merck: Analyzing 2016 Performance and Outlook for 2017 Feb 04 2017 
Is Bristol-Meyers a Buy After 39% Price Decline? Jan 29 2017 
US Market Indexes Lower on Monday Jan 24 2017 
US Market Indexes Lower for the Week Jan 21 2017 

More From Other Websites
UPDATE 2-Roche MS drug Ocrevus approved by FDA after 3-month delay Mar 29 2017
10 Biggest Recent Accounting Scandals in America Mar 27 2017
New budget test puts UK on front line in global drug price fight Mar 27 2017
Merck's Ketruda Gets Positive CHMP Opinion for Lymphoma Mar 27 2017
Chinese drug approval boosts AstraZeneca's lung cancer hopes Mar 27 2017
Trump, Ryan Spike Health Care Vote in Setback for President, GOP Mar 24 2017
How Does Merck’s Valuation Compare to Peers? Mar 24 2017
Merck Keytruda Gets CHMP Nod for Hodgkin's Lymphoma Mar 24 2017
[$$] Merck wins approval for skin cancer treatment Mar 24 2017
European Medicines Agency’s CHMP Recommends Approval of Merck’s KEYTRUDA® (pembrolizumab) for... Mar 24 2017
European Medicines Agency’s CHMP Recommends Approval of Merck’s KEYTRUDA® (pembrolizumab) for... Mar 24 2017
Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment Mar 24 2017
Pfizer, Merck KGaA Get FDA Nod for Skin Cancer Drug (PFE) Mar 24 2017
Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month Mar 24 2017
Merck Closes Acquisition of Controlling Stake in Vallee S.A Mar 23 2017
Merck Animal Health Completes Acquisition of Vallée S.A. Mar 22 2017
Merck must face renewed Fosamax warning claims -U.S. appeals court Mar 22 2017
Merck Osteoporosis Drug Linked to Thigh Fractures Mar 22 2017
U.S. appeals court revives Fosamax warning claims against Merck Mar 22 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)